New Aspects of Vascular Calcification: Histone Deacetylases and Beyond

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2017 Sep 30

PMID 28960024

Citations 14

Authors

Duk Hwa Kwon

Young Kook Kim

Hyun Kook

Affiliations

Soon will be listed here.

Abstract

Vascular calcification is a pathologic phenomenon in which calcium phosphate is ectopically deposited in the arteries. Previously, calcification was considered to be a passive process in response to metabolic diseases, vascular or valvular diseases, or even aging. However, now calcification is recognized as a highly-regulated consequence, like bone formation, and many clinical trials have been carried out to elucidate the correlation between vascular calcification and cardiovascular events and mortality. As a result, vascular calcification has been implicated as an independent risk factor in cardiovascular diseases. Many molecules are now known to be actively associated with this process. Recently, our laboratory found that posttranslational modification of histone deacetylase (HDAC) 1 is actively involved in the development of vascular calcification. In addition, we found that modulation of the activity of HDAC as well as its protein stability by MDM2, an HDAC1-E3 ligase, may be a therapeutic target in vascular calcification. In the present review, we overview the pathomechanism of vascular calcification and the involvement of posttranslational modification of epigenetic regulators.

Citing Articles

Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis.

Yang H, Guo K, Ding P, Ning J, Zhang Y, Wang Y Genes Dis. 2024; 11(6):101216.

PMID: 39281836 PMC: 11396065. DOI: 10.1016/j.gendis.2024.101216.

Comparative analysis of calcified soft tissues revealed shared deregulated pathways.

Ibragimova A, Stanishevskiy Y, Plakkhin A, Zubko A, Darvish N, Koassary A Front Aging Neurosci. 2023; 15:1131548.

PMID: 37441678 PMC: 10335799. DOI: 10.3389/fnagi.2023.1131548.

Vascular Calcification: New Insights Into BMP Type I Receptor A.

Niu Z, Su G, Li T, Yu H, Shen Y, Zhang D Front Pharmacol. 2022; 13:887253.

PMID: 35462911 PMC: 9019578. DOI: 10.3389/fphar.2022.887253.

Vascular Calcification in Chronic Kidney Disease: Diversity in the Vessel Wall.

Dube P, DeRiso A, Patel M, Battepati D, Khatib-Shahidi B, Sharma H Biomedicines. 2021; 9(4).

PMID: 33917965 PMC: 8068383. DOI: 10.3390/biomedicines9040404.

Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.

Skibba M, Drelich A, Poellmann M, Hong S, Brasier A Front Pharmacol. 2021; 11:607689.

PMID: 33384604 PMC: 7770469. DOI: 10.3389/fphar.2020.607689.

References

Hruska K, Mathew S, Saab G . Bone morphogenetic proteins in vascular calcification. Circ Res. 2005; 97(2):105-14. DOI: 10.1161/01.RES.00000175571.53833.6c. View

Vattikuti R, Towler D . Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004; 286(5):E686-96. DOI: 10.1152/ajpendo.00552.2003. View

Choi J, Nam K, Kim J, Baek M, Park J, Park H . Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2005; 25(11):2404-9. DOI: 10.1161/01.ATV.0000184758.07257.88. View

Thompson B, Towler D . Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol. 2012; 8(9):529-43. PMC: 3423589. DOI: 10.1038/nrendo.2012.36. View

Oliner J, Kinzler K, Meltzer P, GEORGE D, Vogelstein B . Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992; 358(6381):80-3. DOI: 10.1038/358080a0. View

Engelse M, Neele J, Bronckers A, Pannekoek H, de Vries C . Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res. 2001; 52(2):281-9. DOI: 10.1016/s0008-6363(01)00375-3. View

Shimizu T, Tanaka T, Iso T, Doi H, Sato H, Kawai-Kowase K . Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol. 2009; 29(7):1104-11. DOI: 10.1161/ATVBAHA.109.187856. View

Williams S, Golden-Mason L, Ferguson B, Schuetze K, Cavasin M, Demos-Davies K . Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J Mol Cell Cardiol. 2013; 67:112-25. PMC: 4120952. DOI: 10.1016/j.yjmcc.2013.12.013. View

Quinn J, Chang H . Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015; 17(1):47-62. DOI: 10.1038/nrg.2015.10. View

10.

Jones P, Altamura S, De Francesco R, Gallinari P, Lahm A, Neddermann P . Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases. Bioorg Med Chem Lett. 2008; 18(6):1814-9. DOI: 10.1016/j.bmcl.2008.02.025. View

11.

Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K . Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89(5):755-64. DOI: 10.1016/s0092-8674(00)80258-5. View

12.

Schmidt A, Hori O, Chen J, Li J, Crandall J, Zhang J . Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of.... J Clin Invest. 1995; 96(3):1395-403. PMC: 185762. DOI: 10.1172/JCI118175. View

13.

Johnson M, Rajamannan N . Diseases of Wnt signaling. Rev Endocr Metab Disord. 2006; 7(1-2):41-9. PMC: 3951857. DOI: 10.1007/s11154-006-9003-3. View

14.

Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P . Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther. 2012; 341(1):285-93. PMC: 3310703. DOI: 10.1124/jpet.111.189910. View

15.

Miyazaki-Anzai S, Masuda M, Demos-Davies K, Keenan A, Saunders S, Masuda R . Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease-induced vascular calcification. J Am Heart Assoc. 2014; 3(3):e000949. PMC: 4309099. DOI: 10.1161/JAHA.114.000949. View

16.

Farrar D, Bond M, RILEY W, Sawyer J . Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation. 1991; 83(5):1754-63. DOI: 10.1161/01.cir.83.5.1754. View

17.

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

18.

Lee H, Lee D, Cho H, Kim S, Iwasaki Y, Kim I . Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Circ Res. 2013; 112(7):1004-12. DOI: 10.1161/CIRCRESAHA.113.301071. View

19.

Derwall M, Malhotra R, Lai C, Beppu Y, Aikawa E, Seehra J . Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler Thromb Vasc Biol. 2012; 32(3):613-22. PMC: 3679546. DOI: 10.1161/ATVBAHA.111.242594. View

20.

DAmelio P, Isaia G, Isaia G . The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. J Endocrinol Invest. 2009; 32(4 Suppl):6-9. View